Physician profile
Christopher S Sipe
NPI 1184767725
$5,199.61
in general payments reported to CMS, 2019-2025
12 companies · $459 in 2025
The $459 reported for 2025 was more than what 86% of Reproductive Endocrinology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $692 · 2020: $2,004 · 2021: $253 · 2022: $585 · 2023: $550 · 2024: $657 · 2025: $459.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,548 · Education: $118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,547.58 |
| Education | $118.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $3,390.54 | 2019-2025 | Menopur, Endometrin |
| Organon LLC | $875.66 | 2021-2025 | Follistim Aq, Ganirelix Acetate, Pregnyl |
| Merck Sharp & Dohme LLC | $294.84 | 2019-2021 | |
| Emd Serono, INC. | $198.35 | 2019-2023 | |
| Coopersurgical, INC. | $120.91 | 2022 | |
| Abbvie INC. | $118.41 | 2022-2024 | Synthroid |
| Galen US INC | $84.29 | 2019 | |
| Myovant Sciences INC. | $29.44 | 2022 | |
| Medtronic, INC. | $28.87 | 2025 | Truclear |
| Avion Pharmaceuticals | $27.69 | 2019-2020 | |
| Ibsa Pharma INC. | $15.95 | 2019 | |
| Vertical Pharmaceuticals, LLC | $14.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Sipe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.